Cite
Jiao C, Zvonkov E, Lai X, et al. 4SCAR2.0: a multi-CAR-T therapy regimen for the treatment of relapsed/refractory B cell lymphomas. Blood Cancer J. 2021;11(3):59doi: 10.1038/s41408-021-00455-x.
Jiao, C., Zvonkov, E., Lai, X., Zhang, R., Liu, Y., Qin, Y., Savchenko, V., Gabeeva, N., Chung, T. H., Sheng, L., & Chang, L. J. (2021). 4SCAR2.0: a multi-CAR-T therapy regimen for the treatment of relapsed/refractory B cell lymphomas. Blood cancer journal, 11(3), 59. https://doi.org/10.1038/s41408-021-00455-x
Jiao, Cheng, et al. "4SCAR2.0: a multi-CAR-T therapy regimen for the treatment of relapsed/refractory B cell lymphomas." Blood cancer journal vol. 11,3 (2021): 59. doi: https://doi.org/10.1038/s41408-021-00455-x
Jiao C, Zvonkov E, Lai X, Zhang R, Liu Y, Qin Y, Savchenko V, Gabeeva N, Chung TH, Sheng L, Chang LJ. 4SCAR2.0: a multi-CAR-T therapy regimen for the treatment of relapsed/refractory B cell lymphomas. Blood Cancer J. 2021 Mar 17;11(3):59. doi: 10.1038/s41408-021-00455-x. PMID: 33727525; PMCID: PMC7966809.
Copy
Download .nbib